Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs41291556

Current Build 157

Released September 3, 2024

Organism
Homo sapiens
Position
chr10:94775416 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
T>C
Variation Type
SNV Single Nucleotide Variation
Frequency
C=0.0024960 (3498/1401440, GnomAD_exomes)
C=0.001462 (387/264690, TOPMED)
C=0.002492 (508/203822, ALFA) (+ 14 more)
C=0.001562 (233/149184, GnomAD_genomes)
C=0.001540 (187/121410, ExAC)
C=0.00177 (23/13006, GO-ESP)
C=0.0011 (7/6404, 1000G_30X)
C=0.0010 (5/5008, 1000G)
C=0.0011 (5/4480, Estonian)
C=0.0018 (7/3854, ALSPAC)
C=0.0032 (12/3708, TWINSUK)
C=0.0006 (2/3296, PRJNA289433)
C=0.0009 (1/1136, Daghestan)
C=0.002 (2/998, GoNL)
C=0.002 (1/600, NorthernSweden)
C=0.002 (1/534, MGP)
C=0.005 (1/216, Qatari)
Clinical Significance
Reported in ClinVar
Gene : Consequence
CYP2C19 : Missense Variant
Publications
21 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 203822 T=0.997508 C=0.002492 0.995045 2.9e-05 0.004926 5
European Sub 174478 T=0.997329 C=0.002671 0.994693 0.000034 0.005273 5
African Sub 4966 T=0.9988 C=0.0012 0.997584 0.0 0.002416 0
African Others Sub 176 T=1.000 C=0.000 1.0 0.0 0.0 N/A
African American Sub 4790 T=0.9987 C=0.0013 0.997495 0.0 0.002505 0
Asian Sub 6350 T=1.0000 C=0.0000 1.0 0.0 0.0 N/A
East Asian Sub 4502 T=1.0000 C=0.0000 1.0 0.0 0.0 N/A
Other Asian Sub 1848 T=1.0000 C=0.0000 1.0 0.0 0.0 N/A
Latin American 1 Sub 794 T=0.999 C=0.001 0.997481 0.0 0.002519 0
Latin American 2 Sub 968 T=0.999 C=0.001 0.997934 0.0 0.002066 0
South Asian Sub 280 T=1.000 C=0.000 1.0 0.0 0.0 N/A
Other Sub 15986 T=0.99787 C=0.00213 0.995746 0.0 0.004254 0


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
gnomAD v4 - Exomes Global Study-wide 1401440 T=0.9975040 C=0.0024960
gnomAD v4 - Exomes European Sub 1165402 T=0.9970860 C=0.0029140
gnomAD v4 - Exomes South Asian Sub 86250 T=0.99942 C=0.00058
gnomAD v4 - Exomes American Sub 44720 T=0.99926 C=0.00074
gnomAD v4 - Exomes East Asian Sub 39700 T=1.00000 C=0.00000
gnomAD v4 - Exomes African Sub 33480 T=0.99970 C=0.00030
gnomAD v4 - Exomes Ashkenazi Jewish Sub 26136 T=0.99992 C=0.00008
gnomAD v4 - Exomes Middle Eastern sub 5752 T=0.9988 C=0.0012
TopMed Global Study-wide 264690 T=0.998538 C=0.001462
Allele Frequency Aggregator Total Global 203822 T=0.997508 C=0.002492
Allele Frequency Aggregator European Sub 174478 T=0.997329 C=0.002671
Allele Frequency Aggregator Other Sub 15986 T=0.99787 C=0.00213
Allele Frequency Aggregator Asian Sub 6350 T=1.0000 C=0.0000
Allele Frequency Aggregator African Sub 4966 T=0.9988 C=0.0012
Allele Frequency Aggregator Latin American 2 Sub 968 T=0.999 C=0.001
Allele Frequency Aggregator Latin American 1 Sub 794 T=0.999 C=0.001
Allele Frequency Aggregator South Asian Sub 280 T=1.000 C=0.000
gnomAD v4 - Genomes Global Study-wide 149184 T=0.998438 C=0.001562
gnomAD v4 - Genomes European Sub 78592 T=0.99757 C=0.00243
gnomAD v4 - Genomes African Sub 41538 T=0.99957 C=0.00043
gnomAD v4 - Genomes American Sub 15300 T=0.99869 C=0.00131
gnomAD v4 - Genomes East Asian Sub 5180 T=1.0000 C=0.0000
gnomAD v4 - Genomes South Asian Sub 4814 T=0.9992 C=0.0008
gnomAD v4 - Genomes Ashkenazi Jewish Sub 3466 T=1.0000 C=0.0000
gnomAD v4 - Genomes Middle Eastern sub 294 T=1.000 C=0.000
ExAC Global Study-wide 121410 T=0.998460 C=0.001540
ExAC Europe Sub 73354 T=0.99778 C=0.00222
ExAC Asian Sub 25166 T=0.99956 C=0.00044
ExAC American Sub 11576 T=0.99957 C=0.00043
ExAC African Sub 10406 T=0.99923 C=0.00077
ExAC Other Sub 908 T=1.000 C=0.000
GO Exome Sequencing Project Global Study-wide 13006 T=0.99823 C=0.00177
GO Exome Sequencing Project European American Sub 8600 T=0.9980 C=0.0020
GO Exome Sequencing Project African American Sub 4406 T=0.9986 C=0.0014
1000Genomes_30X Global Study-wide 6404 T=0.9989 C=0.0011
1000Genomes_30X African Sub 1786 T=0.9994 C=0.0006
1000Genomes_30X Europe Sub 1266 T=0.9961 C=0.0039
1000Genomes_30X South Asian Sub 1202 T=0.9992 C=0.0008
1000Genomes_30X East Asian Sub 1170 T=1.0000 C=0.0000
1000Genomes_30X American Sub 980 T=1.000 C=0.000
1000Genomes Global Study-wide 5008 T=0.9990 C=0.0010
1000Genomes African Sub 1322 T=0.9992 C=0.0008
1000Genomes East Asian Sub 1008 T=1.0000 C=0.0000
1000Genomes Europe Sub 1006 T=0.9970 C=0.0030
1000Genomes South Asian Sub 978 T=0.999 C=0.001
1000Genomes American Sub 694 T=1.000 C=0.000
Genetic variation in the Estonian population Estonian Study-wide 4480 T=0.9989 C=0.0011
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 T=0.9982 C=0.0018
UK 10K study - Twins TWIN COHORT Study-wide 3708 T=0.9968 C=0.0032
MxGDAR/Encodat-PGx Global Study-wide 3296 T=0.9994 C=0.0006
MxGDAR/Encodat-PGx MxGDAR Sub 3296 T=0.9994 C=0.0006
Genome-wide autozygosity in Daghestan Global Study-wide 1136 T=0.9991 C=0.0009
Genome-wide autozygosity in Daghestan Daghestan Sub 628 T=0.998 C=0.002
Genome-wide autozygosity in Daghestan Near_East Sub 144 T=1.000 C=0.000
Genome-wide autozygosity in Daghestan Central Asia Sub 122 T=1.000 C=0.000
Genome-wide autozygosity in Daghestan Europe Sub 108 T=1.000 C=0.000
Genome-wide autozygosity in Daghestan South Asian Sub 98 T=1.00 C=0.00
Genome-wide autozygosity in Daghestan Caucasus Sub 36 T=1.00 C=0.00
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 T=0.998 C=0.002
Northern Sweden ACPOP Study-wide 600 T=0.998 C=0.002
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 T=0.998 C=0.002
Qatari Global Study-wide 216 T=0.995 C=0.005
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 10 NC_000010.11:g.94775416T>C
GRCh37.p13 chr 10 NC_000010.10:g.96535173T>C
CYP2C19 RefSeqGene (LRG_584) NG_008384.3:g.17736T>C
Gene: CYP2C19, cytochrome P450 family 2 subfamily C member 19 (plus strand)
Molecule type Change Amino acid[Codon] SO Term
CYP2C19 transcript NM_000769.4:c.358T>C W [TGG] > R [CGG] Coding Sequence Variant
cytochrome P450 2C19 NP_000760.1:p.Trp120Arg W (Trp) > R (Arg) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: C (allele ID: 47949 )
ClinVar Accession Disease Names Clinical Significance
RCV000394401.12 not provided Other
RCV000782447.11 Clopidogrel response Drug-Response
RCV000782458.9 Clopidogrel response Drug-Response
RCV000782558.10 Citalopram response Drug-Response
RCV000782559.10 Escitalopram response Drug-Response
RCV000782560.10 Citalopram response Drug-Response
RCV000782561.10 Escitalopram response Drug-Response
RCV000782682.10 Escitalopram response Drug-Response
RCV000782683.10 Citalopram response Drug-Response
RCV000782684.10 Escitalopram response Drug-Response
RCV000782685.10 Citalopram response Drug-Response
RCV000782686.10 Escitalopram response Drug-Response
RCV000782687.10 Citalopram response Drug-Response
RCV000782688.10 Escitalopram response Drug-Response
RCV000782699.10 Citalopram response Drug-Response
RCV000782700.10 Escitalopram response Drug-Response
RCV000782725.9 Escitalopram response Drug-Response
RCV000782733.10 Escitalopram response Drug-Response
RCV000782750.10 Citalopram response Drug-Response
RCV000782751.10 Citalopram response Drug-Response
RCV000782752.10 Escitalopram response Drug-Response
RCV000782753.10 Citalopram response Drug-Response
RCV000782754.10 Escitalopram response Drug-Response
RCV000782755.10 Citalopram response Drug-Response
RCV000782756.10 Escitalopram response Drug-Response
RCV000782757.10 Citalopram response Drug-Response
RCV000782758.10 Escitalopram response Drug-Response
RCV000783032.10 Citalopram response Drug-Response
RCV000783033.10 Escitalopram response Drug-Response
RCV000783034.10 Citalopram response Drug-Response
RCV000783035.10 Escitalopram response Drug-Response
RCV000783036.10 Citalopram response Drug-Response
RCV000783037.10 Escitalopram response Drug-Response
RCV000783038.10 Citalopram response Drug-Response
RCV000783039.10 Escitalopram response Drug-Response
RCV000783040.10 Citalopram response Drug-Response
RCV000783104.10 Sertraline response Drug-Response
RCV000783105.10 Sertraline response Drug-Response
RCV000783164.10 Sertraline response Drug-Response
RCV000783165.10 Sertraline response Drug-Response
RCV000783166.10 Sertraline response Drug-Response
RCV000783167.10 Sertraline response Drug-Response
RCV000783168.10 Sertraline response Drug-Response
RCV000783169.10 Sertraline response Drug-Response
RCV000783175.10 Sertraline response Drug-Response
RCV000783181.10 Sertraline response Drug-Response
RCV000783191.10 Sertraline response Drug-Response
RCV000783201.11 Sertraline response Drug-Response
RCV000783202.10 Sertraline response Drug-Response
RCV000783203.10 Sertraline response Drug-Response
RCV000783204.10 Sertraline response Drug-Response
RCV000783205.10 Sertraline response Drug-Response
RCV000783342.10 Sertraline response Drug-Response
RCV000783343.10 Sertraline response Drug-Response
RCV000783344.10 Sertraline response Drug-Response
RCV000783345.10 Sertraline response Drug-Response
RCV000783346.10 Sertraline response Drug-Response
RCV000783347.10 Sertraline response Drug-Response
RCV000783348.10 Sertraline response Drug-Response
RCV000783349.10 Sertraline response Drug-Response
RCV000783490.10 Voriconazole response Drug-Response
RCV000783491.10 Voriconazole response Drug-Response
RCV000783492.10 Voriconazole response Drug-Response
RCV000783493.10 Voriconazole response Drug-Response
RCV000783494.10 Voriconazole response Drug-Response
RCV000783495.10 Voriconazole response Drug-Response
RCV000783496.10 Voriconazole response Drug-Response
RCV000783497.10 Voriconazole response Drug-Response
RCV000783599.10 Voriconazole response Drug-Response
RCV000783600.10 Voriconazole response Drug-Response
RCV000783601.10 Voriconazole response Drug-Response
RCV000783602.10 Voriconazole response Drug-Response
RCV000783626.10 Voriconazole response Drug-Response
RCV000783635.10 Voriconazole response Drug-Response
RCV000783638.10 Voriconazole response Drug-Response
RCV000783643.10 Voriconazole response Drug-Response
RCV000783644.10 Voriconazole response Drug-Response
RCV000783645.10 Voriconazole response Drug-Response
RCV000783646.10 Voriconazole response Drug-Response
RCV000783647.11 Voriconazole response Drug-Response
RCV000783659.9 CYP2C19: no function Drug-Response
RCV000783665.10 Clopidogrel response Drug-Response
RCV000783673.10 Clopidogrel response Drug-Response
RCV000783680.10 Clopidogrel response Drug-Response
RCV000783683.10 Clopidogrel response Drug-Response
RCV000783687.10 Clopidogrel response Drug-Response
RCV000783690.10 Clopidogrel response Drug-Response
RCV000783692.10 Clopidogrel response Drug-Response
RCV000783693.11 Clopidogrel response Drug-Response
RCV000783723.10 Citalopram response Drug-Response
RCV000783724.10 Escitalopram response Drug-Response
RCV000783784.10 Escitalopram response Drug-Response
RCV000783785.10 Citalopram response Drug-Response
RCV000783786.10 Escitalopram response Drug-Response
RCV000783787.11 Citalopram response Drug-Response
RCV000783788.11 Escitalopram response Drug-Response
RCV000783789.10 Citalopram response Drug-Response
RCV000783790.10 Escitalopram response Drug-Response
RCV000783791.10 Citalopram response Drug-Response
RCV000783912.10 Citalopram response Drug-Response
RCV000783913.10 Escitalopram response Drug-Response
RCV000783914.10 Citalopram response Drug-Response
RCV000783915.10 Escitalopram response Drug-Response
RCV000783916.10 Citalopram response Drug-Response
RCV000783946.10 Citalopram response Drug-Response
RCV000783947.10 Escitalopram response Drug-Response
RCV000783957.9 Citalopram response Drug-Response
RCV000783965.10 Citalopram response Drug-Response
RCV000783970.10 Citalopram response Drug-Response
RCV000783971.10 Escitalopram response Drug-Response
RCV000783974.10 Escitalopram response Drug-Response
RCV000783983.11 Citalopram response Drug-Response
RCV000783984.11 Escitalopram response Drug-Response
RCV000784262.10 Escitalopram response Drug-Response
RCV000784263.10 Citalopram response Drug-Response
RCV000784264.10 Escitalopram response Drug-Response
RCV000784265.10 Citalopram response Drug-Response
RCV000784266.10 Escitalopram response Drug-Response
RCV000784267.10 Citalopram response Drug-Response
RCV000784268.10 Escitalopram response Drug-Response
RCV000784269.10 Citalopram response Drug-Response
RCV000784270.10 Escitalopram response Drug-Response
RCV000784271.10 Citalopram response Drug-Response
RCV000784272.10 Escitalopram response Drug-Response
RCV000784304.10 Sertraline response Drug-Response
RCV000784335.10 Sertraline response Drug-Response
RCV000784336.11 Sertraline response Drug-Response
RCV000784337.10 Sertraline response Drug-Response
RCV000784338.10 Sertraline response Drug-Response
RCV000784420.9 Sertraline response Drug-Response
RCV000784427.10 Sertraline response Drug-Response
RCV000784432.10 Sertraline response Drug-Response
RCV000784580.10 Sertraline response Drug-Response
RCV000784581.10 Sertraline response Drug-Response
RCV000784727.10 Voriconazole response Drug-Response
RCV000784728.10 Voriconazole response Drug-Response
RCV000784741.10 Voriconazole response Drug-Response
RCV000784770.10 Voriconazole response Drug-Response
RCV000784771.10 Voriconazole response Drug-Response
RCV000784772.10 Voriconazole response Drug-Response
RCV000784773.11 Voriconazole response Drug-Response
RCV000784774.10 Voriconazole response Drug-Response
RCV000784775.10 Voriconazole response Drug-Response
RCV000784821.10 Voriconazole response Drug-Response
RCV000784822.10 Voriconazole response Drug-Response
RCV000784840.10 Voriconazole response Drug-Response
RCV000784855.9 Voriconazole response Drug-Response
RCV000784862.10 Voriconazole response Drug-Response
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement T= C
GRCh38.p14 chr 10 NC_000010.11:g.94775416= NC_000010.11:g.94775416T>C
GRCh37.p13 chr 10 NC_000010.10:g.96535173= NC_000010.10:g.96535173T>C
CYP2C19 RefSeqGene (LRG_584) NG_008384.3:g.17736= NG_008384.3:g.17736T>C
CYP2C19 transcript NM_000769.4:c.358= NM_000769.4:c.358T>C
CYP2C19 transcript NM_000769.3:c.358= NM_000769.3:c.358T>C
CYP2C19 transcript NM_000769.2:c.358= NM_000769.2:c.358T>C
CYP2C19 transcript NM_000769.1:c.358= NM_000769.1:c.358T>C
cytochrome P450 2C19 NP_000760.1:p.Trp120= NP_000760.1:p.Trp120Arg
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

71 SubSNP, 17 Frequency, 148 ClinVar submissions
No Submitter Submission ID Date (Build)
1 SI_EXO ss52064777 Oct 18, 2006 (127)
2 ILLUMINA ss75254071 Dec 07, 2007 (129)
3 SNP500CANCER ss105438122 Feb 05, 2009 (130)
4 ILLUMINA ss169136178 Jul 04, 2010 (132)
5 NHLBI-ESP ss342304102 May 09, 2011 (134)
6 1000GENOMES ss488937553 May 04, 2012 (137)
7 EXOME_CHIP ss491438600 May 04, 2012 (137)
8 CLINSEQ_SNP ss491629930 May 04, 2012 (137)
9 ILLUMINA ss537652768 Sep 08, 2015 (146)
10 ILLUMINA ss780888999 Aug 21, 2014 (142)
11 ILLUMINA ss783575245 Aug 21, 2014 (142)
12 CLINVAR ss831879133 Nov 05, 2013 (136)
13 EVA-GONL ss987804489 Aug 21, 2014 (142)
14 1000GENOMES ss1338623583 Aug 21, 2014 (142)
15 HAMMER_LAB ss1397589436 Sep 08, 2015 (146)
16 EVA_DECODE ss1597477795 Apr 01, 2015 (144)
17 EVA_UK10K_ALSPAC ss1625196095 Apr 01, 2015 (144)
18 EVA_UK10K_TWINSUK ss1668190128 Apr 01, 2015 (144)
19 EVA_EXAC ss1690011822 Apr 01, 2015 (144)
20 EVA_MGP ss1711265769 Apr 01, 2015 (144)
21 ILLUMINA ss1751988270 Sep 08, 2015 (146)
22 ILLUMINA ss1917849819 Feb 12, 2016 (147)
23 WEILL_CORNELL_DGM ss1931170501 Feb 12, 2016 (147)
24 ILLUMINA ss1946289775 Feb 12, 2016 (147)
25 ILLUMINA ss1959284941 Feb 12, 2016 (147)
26 HUMAN_LONGEVITY ss2177148210 Dec 20, 2016 (150)
27 ILLUMINA ss2632748371 Nov 08, 2017 (151)
28 GNOMAD ss2738420691 Nov 08, 2017 (151)
29 GNOMAD ss2748441458 Nov 08, 2017 (151)
30 GNOMAD ss2892128019 Nov 08, 2017 (151)
31 AFFY ss2984919980 Nov 08, 2017 (151)
32 AFFY ss2985568269 Nov 08, 2017 (151)
33 SWEGEN ss3006966009 Nov 08, 2017 (151)
34 ILLUMINA ss3021264870 Nov 08, 2017 (151)
35 ILLUMINA ss3626509899 Oct 12, 2018 (152)
36 ILLUMINA ss3626509900 Oct 12, 2018 (152)
37 ILLUMINA ss3634417809 Oct 12, 2018 (152)
38 ILLUMINA ss3637867221 Oct 12, 2018 (152)
39 ILLUMINA ss3640125150 Oct 12, 2018 (152)
40 ILLUMINA ss3642869295 Oct 12, 2018 (152)
41 ILLUMINA ss3644542522 Oct 12, 2018 (152)
42 ILLUMINA ss3651623295 Oct 12, 2018 (152)
43 ILLUMINA ss3653690715 Oct 12, 2018 (152)
44 EGCUT_WGS ss3674378186 Jul 13, 2019 (153)
45 EVA_DECODE ss3690461893 Jul 13, 2019 (153)
46 ILLUMINA ss3725179478 Jul 13, 2019 (153)
47 ACPOP ss3737585576 Jul 13, 2019 (153)
48 ILLUMINA ss3744369908 Jul 13, 2019 (153)
49 ILLUMINA ss3744718780 Jul 13, 2019 (153)
50 ILLUMINA ss3772219136 Jul 13, 2019 (153)
51 EVA ss3824540917 Apr 26, 2020 (154)
52 EVA ss3984449111 Apr 26, 2021 (155)
53 EVA ss3986493457 Apr 26, 2021 (155)
54 TOPMED ss4862626881 Apr 26, 2021 (155)
55 EVA ss6253826620 Nov 01, 2024 (157)
56 EVA ss6307410197 Nov 01, 2024 (157)
57 EVA ss6322395604 Nov 01, 2024 (157)
58 EVA ss6403982922 Nov 01, 2024 (157)
59 GNOMAD ss6440423226 Nov 01, 2024 (157)
60 GNOMAD ss6859877990 Nov 01, 2024 (157)
61 EVA ss8237655804 Nov 01, 2024 (157)
62 1000G_HIGH_COVERAGE ss8285087931 Nov 01, 2024 (157)
63 EVA ss8395323214 Nov 01, 2024 (157)
64 EVA ss8512473892 Nov 01, 2024 (157)
65 1000G_HIGH_COVERAGE ss8579564843 Nov 01, 2024 (157)
66 SANFORD_IMAGENETICS ss8624255704 Nov 01, 2024 (157)
67 SANFORD_IMAGENETICS ss8649885916 Nov 01, 2024 (157)
68 EVA ss8847605627 Nov 01, 2024 (157)
69 EVA ss8880085930 Nov 01, 2024 (157)
70 EVA ss8941172465 Nov 01, 2024 (157)
71 EVA ss8979335322 Nov 01, 2024 (157)
72 1000Genomes NC_000010.10 - 96535173 Oct 12, 2018 (152)
73 1000Genomes_30X NC_000010.11 - 94775416 Nov 01, 2024 (157)
74 The Avon Longitudinal Study of Parents and Children NC_000010.10 - 96535173 Oct 12, 2018 (152)
75 Genome-wide autozygosity in Daghestan NC_000010.9 - 96525163 Apr 26, 2020 (154)
76 Genetic variation in the Estonian population NC_000010.10 - 96535173 Oct 12, 2018 (152)
77 ExAC NC_000010.10 - 96535173 Oct 12, 2018 (152)
78 gnomAD v4 - Exomes NC_000010.11 - 94775416 Nov 01, 2024 (157)
79 gnomAD v4 - Genomes NC_000010.11 - 94775416 Nov 01, 2024 (157)
80 GO Exome Sequencing Project NC_000010.10 - 96535173 Oct 12, 2018 (152)
81 Genome of the Netherlands Release 5 NC_000010.10 - 96535173 Apr 26, 2020 (154)
82 Medical Genome Project healthy controls from Spanish population NC_000010.10 - 96535173 Apr 26, 2020 (154)
83 Northern Sweden NC_000010.10 - 96535173 Jul 13, 2019 (153)
84 MxGDAR/Encodat-PGx NC_000010.10 - 96535173 Apr 26, 2021 (155)
85 Qatari NC_000010.10 - 96535173 Apr 26, 2020 (154)
86 TopMed NC_000010.11 - 94775416 Apr 26, 2021 (155)
87 UK 10K study - Twins NC_000010.10 - 96535173 Oct 12, 2018 (152)
88 ALFA NC_000010.11 - 94775416 Nov 01, 2024 (157)
89 ClinVar RCV000394401.12 Nov 01, 2024 (157)
90 ClinVar RCV000782447.11 Nov 01, 2024 (157)
91 ClinVar RCV000782458.9 Nov 01, 2024 (157)
92 ClinVar RCV000782558.10 Nov 01, 2024 (157)
93 ClinVar RCV000782559.10 Nov 01, 2024 (157)
94 ClinVar RCV000782560.10 Nov 01, 2024 (157)
95 ClinVar RCV000782561.10 Nov 01, 2024 (157)
96 ClinVar RCV000782682.10 Nov 01, 2024 (157)
97 ClinVar RCV000782683.10 Nov 01, 2024 (157)
98 ClinVar RCV000782684.10 Nov 01, 2024 (157)
99 ClinVar RCV000782685.10 Nov 01, 2024 (157)
100 ClinVar RCV000782686.10 Nov 01, 2024 (157)
101 ClinVar RCV000782687.10 Nov 01, 2024 (157)
102 ClinVar RCV000782688.10 Nov 01, 2024 (157)
103 ClinVar RCV000782699.10 Nov 01, 2024 (157)
104 ClinVar RCV000782700.10 Nov 01, 2024 (157)
105 ClinVar RCV000782725.9 Nov 01, 2024 (157)
106 ClinVar RCV000782733.10 Nov 01, 2024 (157)
107 ClinVar RCV000782750.10 Nov 01, 2024 (157)
108 ClinVar RCV000782751.10 Nov 01, 2024 (157)
109 ClinVar RCV000782752.10 Nov 01, 2024 (157)
110 ClinVar RCV000782753.10 Nov 01, 2024 (157)
111 ClinVar RCV000782754.10 Nov 01, 2024 (157)
112 ClinVar RCV000782755.10 Nov 01, 2024 (157)
113 ClinVar RCV000782756.10 Nov 01, 2024 (157)
114 ClinVar RCV000782757.10 Nov 01, 2024 (157)
115 ClinVar RCV000782758.10 Nov 01, 2024 (157)
116 ClinVar RCV000783032.10 Nov 01, 2024 (157)
117 ClinVar RCV000783033.10 Nov 01, 2024 (157)
118 ClinVar RCV000783034.10 Nov 01, 2024 (157)
119 ClinVar RCV000783035.10 Nov 01, 2024 (157)
120 ClinVar RCV000783036.10 Nov 01, 2024 (157)
121 ClinVar RCV000783037.10 Nov 01, 2024 (157)
122 ClinVar RCV000783038.10 Nov 01, 2024 (157)
123 ClinVar RCV000783039.10 Nov 01, 2024 (157)
124 ClinVar RCV000783040.10 Nov 01, 2024 (157)
125 ClinVar RCV000783104.10 Nov 01, 2024 (157)
126 ClinVar RCV000783105.10 Nov 01, 2024 (157)
127 ClinVar RCV000783164.10 Nov 01, 2024 (157)
128 ClinVar RCV000783165.10 Nov 01, 2024 (157)
129 ClinVar RCV000783166.10 Nov 01, 2024 (157)
130 ClinVar RCV000783167.10 Nov 01, 2024 (157)
131 ClinVar RCV000783168.10 Nov 01, 2024 (157)
132 ClinVar RCV000783169.10 Nov 01, 2024 (157)
133 ClinVar RCV000783175.10 Nov 01, 2024 (157)
134 ClinVar RCV000783181.10 Nov 01, 2024 (157)
135 ClinVar RCV000783191.10 Nov 01, 2024 (157)
136 ClinVar RCV000783201.11 Nov 01, 2024 (157)
137 ClinVar RCV000783202.10 Nov 01, 2024 (157)
138 ClinVar RCV000783203.10 Nov 01, 2024 (157)
139 ClinVar RCV000783204.10 Nov 01, 2024 (157)
140 ClinVar RCV000783205.10 Nov 01, 2024 (157)
141 ClinVar RCV000783342.10 Nov 01, 2024 (157)
142 ClinVar RCV000783343.10 Nov 01, 2024 (157)
143 ClinVar RCV000783344.10 Nov 01, 2024 (157)
144 ClinVar RCV000783345.10 Nov 01, 2024 (157)
145 ClinVar RCV000783346.10 Nov 01, 2024 (157)
146 ClinVar RCV000783347.10 Nov 01, 2024 (157)
147 ClinVar RCV000783348.10 Nov 01, 2024 (157)
148 ClinVar RCV000783349.10 Nov 01, 2024 (157)
149 ClinVar RCV000783490.10 Nov 01, 2024 (157)
150 ClinVar RCV000783491.10 Nov 01, 2024 (157)
151 ClinVar RCV000783492.10 Nov 01, 2024 (157)
152 ClinVar RCV000783493.10 Nov 01, 2024 (157)
153 ClinVar RCV000783494.10 Nov 01, 2024 (157)
154 ClinVar RCV000783495.10 Nov 01, 2024 (157)
155 ClinVar RCV000783496.10 Nov 01, 2024 (157)
156 ClinVar RCV000783497.10 Nov 01, 2024 (157)
157 ClinVar RCV000783599.10 Nov 01, 2024 (157)
158 ClinVar RCV000783600.10 Nov 01, 2024 (157)
159 ClinVar RCV000783601.10 Nov 01, 2024 (157)
160 ClinVar RCV000783602.10 Nov 01, 2024 (157)
161 ClinVar RCV000783626.10 Nov 01, 2024 (157)
162 ClinVar RCV000783635.10 Nov 01, 2024 (157)
163 ClinVar RCV000783638.10 Nov 01, 2024 (157)
164 ClinVar RCV000783643.10 Nov 01, 2024 (157)
165 ClinVar RCV000783644.10 Nov 01, 2024 (157)
166 ClinVar RCV000783645.10 Nov 01, 2024 (157)
167 ClinVar RCV000783646.10 Nov 01, 2024 (157)
168 ClinVar RCV000783647.11 Nov 01, 2024 (157)
169 ClinVar RCV000783659.9 Nov 01, 2024 (157)
170 ClinVar RCV000783665.10 Nov 01, 2024 (157)
171 ClinVar RCV000783673.10 Nov 01, 2024 (157)
172 ClinVar RCV000783680.10 Nov 01, 2024 (157)
173 ClinVar RCV000783683.10 Nov 01, 2024 (157)
174 ClinVar RCV000783687.10 Nov 01, 2024 (157)
175 ClinVar RCV000783690.10 Nov 01, 2024 (157)
176 ClinVar RCV000783692.10 Nov 01, 2024 (157)
177 ClinVar RCV000783693.11 Nov 01, 2024 (157)
178 ClinVar RCV000783723.10 Nov 01, 2024 (157)
179 ClinVar RCV000783724.10 Nov 01, 2024 (157)
180 ClinVar RCV000783784.10 Nov 01, 2024 (157)
181 ClinVar RCV000783785.10 Nov 01, 2024 (157)
182 ClinVar RCV000783786.10 Nov 01, 2024 (157)
183 ClinVar RCV000783787.11 Nov 01, 2024 (157)
184 ClinVar RCV000783788.11 Nov 01, 2024 (157)
185 ClinVar RCV000783789.10 Nov 01, 2024 (157)
186 ClinVar RCV000783790.10 Nov 01, 2024 (157)
187 ClinVar RCV000783791.10 Nov 01, 2024 (157)
188 ClinVar RCV000783912.10 Nov 01, 2024 (157)
189 ClinVar RCV000783913.10 Nov 01, 2024 (157)
190 ClinVar RCV000783914.10 Nov 01, 2024 (157)
191 ClinVar RCV000783915.10 Nov 01, 2024 (157)
192 ClinVar RCV000783916.10 Nov 01, 2024 (157)
193 ClinVar RCV000783946.10 Nov 01, 2024 (157)
194 ClinVar RCV000783947.10 Nov 01, 2024 (157)
195 ClinVar RCV000783957.9 Nov 01, 2024 (157)
196 ClinVar RCV000783965.10 Nov 01, 2024 (157)
197 ClinVar RCV000783970.10 Nov 01, 2024 (157)
198 ClinVar RCV000783971.10 Nov 01, 2024 (157)
199 ClinVar RCV000783974.10 Nov 01, 2024 (157)
200 ClinVar RCV000783983.11 Nov 01, 2024 (157)
201 ClinVar RCV000783984.11 Nov 01, 2024 (157)
202 ClinVar RCV000784262.10 Nov 01, 2024 (157)
203 ClinVar RCV000784263.10 Nov 01, 2024 (157)
204 ClinVar RCV000784264.10 Nov 01, 2024 (157)
205 ClinVar RCV000784265.10 Nov 01, 2024 (157)
206 ClinVar RCV000784266.10 Nov 01, 2024 (157)
207 ClinVar RCV000784267.10 Nov 01, 2024 (157)
208 ClinVar RCV000784268.10 Nov 01, 2024 (157)
209 ClinVar RCV000784269.10 Nov 01, 2024 (157)
210 ClinVar RCV000784270.10 Nov 01, 2024 (157)
211 ClinVar RCV000784271.10 Nov 01, 2024 (157)
212 ClinVar RCV000784272.10 Nov 01, 2024 (157)
213 ClinVar RCV000784304.10 Nov 01, 2024 (157)
214 ClinVar RCV000784335.10 Nov 01, 2024 (157)
215 ClinVar RCV000784336.11 Nov 01, 2024 (157)
216 ClinVar RCV000784337.10 Nov 01, 2024 (157)
217 ClinVar RCV000784338.10 Nov 01, 2024 (157)
218 ClinVar RCV000784420.9 Nov 01, 2024 (157)
219 ClinVar RCV000784427.10 Nov 01, 2024 (157)
220 ClinVar RCV000784432.10 Nov 01, 2024 (157)
221 ClinVar RCV000784580.10 Nov 01, 2024 (157)
222 ClinVar RCV000784581.10 Nov 01, 2024 (157)
223 ClinVar RCV000784727.10 Nov 01, 2024 (157)
224 ClinVar RCV000784728.10 Nov 01, 2024 (157)
225 ClinVar RCV000784741.10 Nov 01, 2024 (157)
226 ClinVar RCV000784770.10 Nov 01, 2024 (157)
227 ClinVar RCV000784771.10 Nov 01, 2024 (157)
228 ClinVar RCV000784772.10 Nov 01, 2024 (157)
229 ClinVar RCV000784773.11 Nov 01, 2024 (157)
230 ClinVar RCV000784774.10 Nov 01, 2024 (157)
231 ClinVar RCV000784775.10 Nov 01, 2024 (157)
232 ClinVar RCV000784821.10 Nov 01, 2024 (157)
233 ClinVar RCV000784822.10 Nov 01, 2024 (157)
234 ClinVar RCV000784840.10 Nov 01, 2024 (157)
235 ClinVar RCV000784855.9 Nov 01, 2024 (157)
236 ClinVar RCV000784862.10 Nov 01, 2024 (157)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
60866, ss491629930, ss1397589436, ss1597477795, ss3642869295 NC_000010.9:96525162:T:C NC_000010.11:94775415:T:C (self)
51055010, 28345641, 20116434, 241452, 998600, 12639354, 381529, 10870441, 2112, 13212431, 28345641, ss342304102, ss488937553, ss491438600, ss537652768, ss780888999, ss783575245, ss987804489, ss1338623583, ss1625196095, ss1668190128, ss1690011822, ss1711265769, ss1751988270, ss1917849819, ss1931170501, ss1946289775, ss1959284941, ss2632748371, ss2738420691, ss2748441458, ss2892128019, ss2984919980, ss2985568269, ss3006966009, ss3021264870, ss3626509899, ss3626509900, ss3634417809, ss3637867221, ss3640125150, ss3644542522, ss3651623295, ss3653690715, ss3674378186, ss3737585576, ss3744369908, ss3744718780, ss3772219136, ss3824540917, ss3984449111, ss3986493457, ss6253826620, ss6307410197, ss6322395604, ss6403982922, ss8395323214, ss8512473892, ss8624255704, ss8649885916, ss8847605627, ss8941172465, ss8979335322 NC_000010.10:96535172:T:C NC_000010.11:94775415:T:C (self)
RCV000394401.12, RCV000782447.11, RCV000782458.9, RCV000782558.10, RCV000782559.10, RCV000782560.10, RCV000782561.10, RCV000782682.10, RCV000782683.10, RCV000782684.10, RCV000782685.10, RCV000782686.10, RCV000782687.10, RCV000782688.10, RCV000782699.10, RCV000782700.10, RCV000782725.9, RCV000782733.10, RCV000782750.10, RCV000782751.10, RCV000782752.10, RCV000782753.10, RCV000782754.10, RCV000782755.10, RCV000782756.10, RCV000782757.10, RCV000782758.10, RCV000783032.10, RCV000783033.10, RCV000783034.10, RCV000783035.10, RCV000783036.10, RCV000783037.10, RCV000783038.10, RCV000783039.10, RCV000783040.10, RCV000783104.10, RCV000783105.10, RCV000783164.10, RCV000783165.10, RCV000783166.10, RCV000783167.10, RCV000783168.10, RCV000783169.10, RCV000783175.10, RCV000783181.10, RCV000783191.10, RCV000783201.11, RCV000783202.10, RCV000783203.10, RCV000783204.10, RCV000783205.10, RCV000783342.10, RCV000783343.10, RCV000783344.10, RCV000783345.10, RCV000783346.10, RCV000783347.10, RCV000783348.10, RCV000783349.10, RCV000783490.10, RCV000783491.10, RCV000783492.10, RCV000783493.10, RCV000783494.10, RCV000783495.10, RCV000783496.10, RCV000783497.10, RCV000783599.10, RCV000783600.10, RCV000783601.10, RCV000783602.10, RCV000783626.10, RCV000783635.10, RCV000783638.10, RCV000783643.10, RCV000783644.10, RCV000783645.10, RCV000783646.10, RCV000783647.11, RCV000783659.9, RCV000783665.10, RCV000783673.10, RCV000783680.10, RCV000783683.10, RCV000783687.10, RCV000783690.10, RCV000783692.10, RCV000783693.11, RCV000783723.10, RCV000783724.10, RCV000783784.10, RCV000783785.10, RCV000783786.10, RCV000783787.11, RCV000783788.11, RCV000783789.10, RCV000783790.10, RCV000783791.10, RCV000783912.10, RCV000783913.10, RCV000783914.10, RCV000783915.10, RCV000783916.10, RCV000783946.10, RCV000783947.10, RCV000783957.9, RCV000783965.10, RCV000783970.10, RCV000783971.10, RCV000783974.10, RCV000783983.11, RCV000783984.11, RCV000784262.10, RCV000784263.10, RCV000784264.10, RCV000784265.10, RCV000784266.10, RCV000784267.10, RCV000784268.10, RCV000784269.10, RCV000784270.10, RCV000784271.10, RCV000784272.10, RCV000784304.10, RCV000784335.10, RCV000784336.11, RCV000784337.10, RCV000784338.10, RCV000784420.9, RCV000784427.10, RCV000784432.10, RCV000784580.10, RCV000784581.10, RCV000784727.10, RCV000784728.10, RCV000784741.10, RCV000784770.10, RCV000784771.10, RCV000784772.10, RCV000784773.11, RCV000784774.10, RCV000784775.10, RCV000784821.10, RCV000784822.10, RCV000784840.10, RCV000784855.9, RCV000784862.10, 67090778, 35745065, 387013735, 78172536, 9850458987, ss831879133, ss2177148210, ss3690461893, ss3725179478, ss4862626881, ss6440423226, ss6859877990, ss8237655804, ss8285087931, ss8579564843, ss8880085930 NC_000010.11:94775415:T:C NC_000010.11:94775415:T:C (self)
ss52064777 NT_030059.12:15283698:T:C NC_000010.11:94775415:T:C (self)
ss75254071, ss105438122, ss169136178 NT_030059.13:47339636:T:C NC_000010.11:94775415:T:C (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

21 citations for rs41291556
PMID Title Author Year Journal
20978260 Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. Mega JL et al. 2010 JAMA
21358751 Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness. Scott SA et al. 2012 The pharmacogenomics journal
21816733 Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis. Bauer T et al. 2011 BMJ (Clinical research ed.)
24944790 Screening for 392 polymorphisms in 141 pharmacogenes. Kim JY et al. 2014 Biomedical reports
25714468 A systematic approach to the reporting of medically relevant findings from whole genome sequencing. McLaughlin HM et al. 2014 BMC medical genetics
26323597 Interindividual variability of CYP2C19-catalyzed drug metabolism due to differences in gene diplotypes and cytochrome P450 oxidoreductase content. Shirasaka Y et al. 2016 The pharmacogenomics journal
26757134 Genetic and Nongenetic Factors Affecting Clopidogrel Response in the Egyptian Population. Khalil BM et al. 2016 Clinical and translational science
26785747 Polymorphisms in genes involved in the absorption, distribution, metabolism, and excretion of drugs in the Kazakhs of Kazakhstan. Iskakova AN et al. 2016 BMC genetics
26857559 A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers. León-Cachón RBR et al. 2016 BMC cancer
29193749 Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years. Borobia AM et al. 2018 Clinical and translational science
29681089 Genetic variation in biotransformation enzymes, air pollution exposures, and risk of spina bifida. Padula AM et al. 2018 American journal of medical genetics. Part A
30093869 Biological Predictors of Clozapine Response: A Systematic Review. Samanaite R et al. 2018 Frontiers in psychiatry
30214584 Influence of SLCO1B1 in gastric cancer patients treated with EOF chemotherapy. Feng W et al. 2018 Oncology letters
30758238 Development and Cross-Validation of High-Resolution Melting Analysis-Based Cardiovascular Pharmacogenetics Genotyping Panel. Langaee T et al. 2019 Genetic testing and molecular biomarkers
31019283 Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests. Thauvin-Robinet C et al. 2019 European journal of human genetics
33519226 Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon. Fernandes MR et al. 2021 Pharmacogenomics and personalized medicine
33569925 Gene-environment interactions between air pollution and biotransformation enzymes and risk of birth defects. Padula AM et al. 2021 Birth defects research
34621706 Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform. Kim B et al. 2021 Translational and clinical pharmacology
34690761 Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin. Villapalos-García G et al. 2021 Frontiers in pharmacology
35089958 Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population. Goljan E et al. 2022 PloS one
36164570 Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard. Alshabeeb MA et al. 2022 Saudi pharmaceutical journal
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post825+45319f0